Showing results (181-190 of 5,331) with videos related to
Sort By:
Pageof 534
Blood|November 25, 2020
Persistent challenges with treating multiple myeloma earlyAaron M Goodman, Myung S Kim, Vinay PrasadSeminars in Oncology|April 12, 2017
What constitutes an "unmet medical need" in oncology? An empirical evaluation of author usage in the biomedical literatureEric Lu, Joseph Shatzel, Florence Shin, et al.JAMA Network Open|May 16, 2022
Association of Adjuvant or Metastatic Setting With Discontinuation of Cancer Drugs in Clinical TrialsNibras Ahmed, Yasaswi Vengalasetti, Alyson Haslam, et al.Applied and Environmental Microbiology|September 30, 2008
Effect of temperature on the cannibalistic behavior of Bacillus subtilisSubir Kumar Nandy, Vinay Prasad, K V VenkateshThe Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 31, 2009
The effect of maternal thrombophilia on placental abruption: Histologic correlatesWendy L Kinzler, Vinay Prasad, Cande V Ananth, et al.European Journal of Clinical Investigation|July 30, 2024
Evidence base for yearly respiratory virus vaccines: Current status and proposed improved strategiesMariana Barosa, John P A Ioannidis, Vinay PrasadTranslational Oncology|May 21, 2025
FRESCO-2 trial and fruquintinib: A clearer picture of the control armSruthi Ranganathan, Alyson Haslam, Timothée Olivier, et al.The Lancet. Oncology|July 14, 2024
Clinical benefit, reimbursement outcomes, and prices of FDA-approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland: a retrospective, comparative analysisKristina Jenei, Arianna Gentilini, Alyson Haslam, et al.European Urology|March 16, 2021
Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?Daniel H Kwon, Christopher M Booth, Vinay PrasadBMC Cancer|January 13, 2023
Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkersAlyson Haslam, Timothée Olivier, Jordan Tuia, et al.Pageof 534